{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:25:56Z","timestamp":1790724356770,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/nchembio.2056","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T18:52:46Z","timestamp":1459191166000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-4219","authenticated-orcid":false,"given":"Geoffrey A","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Taunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"BFnchembio2056_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nri2580","volume":"9","author":"Y Rochman","year":"2009","unstructured":"Rochman, Y., Spolski, R. & Leonard, W.J. New insights into the regulation of T cells by \u03b3(c) family cytokines. Nat. Rev. Immunol. 9, 480\u2013490 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnchembio2056_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.7973659","volume":"266","author":"T Miyazaki","year":"1994","unstructured":"Miyazaki, T. et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045\u20131047 (1994).","journal-title":"Science"},{"key":"BFnchembio2056_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi, K., Laurence, A. & O'Shea, J.J. Janus kinases in immune cell signaling. Immunol. Rev. 228, 273\u2013287 (2009).","journal-title":"Immunol. Rev."},{"key":"BFnchembio2056_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J.-X. & Leonard, W.J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325 (2013).","journal-title":"Immunity"},{"key":"BFnchembio2056_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.immuni.2012.02.017","volume":"36","author":"J-X Lin","year":"2012","unstructured":"Lin, J.-X. et al. Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36, 586\u2013599 (2012).","journal-title":"Immunity"},{"key":"BFnchembio2056_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","volume":"26","author":"A Laurence","year":"2007","unstructured":"Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371\u2013381 (2007).","journal-title":"Immunity"},{"key":"BFnchembio2056_CR7","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.4049\/jimmunol.179.8.5301","volume":"179","author":"HM Lockyer","year":"2007","unstructured":"Lockyer, H.M., Tran, E. & Nelson, B.H. STAT5 is essential for Akt\/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. J. Immunol. 179, 5301\u20135308 (2007).","journal-title":"J. Immunol."},{"key":"BFnchembio2056_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1073\/pnas.0507350103","volume":"103","author":"Z Yao","year":"2006","unstructured":"Yao, Z. et al. Stat5a\/b are essential for normal lymphoid development and differentiation. Proc. Natl. Acad. Sci. USA 103, 1000\u20131005 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2056_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1126\/science.270.5237.794","volume":"270","author":"DC Thomis","year":"1995","unstructured":"Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.H. & Berg, L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794\u2013797 (1995).","journal-title":"Science"},{"key":"BFnchembio2056_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.185.2.197","volume":"185","author":"DC Thomis","year":"1997","unstructured":"Thomis, D.C. & Berg, L.J. Peripheral expression of Jak3 is required to maintain T lymphocyte function. J. Exp. Med. 185, 197\u2013206 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnchembio2056_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/10428199909167389","volume":"32","author":"BA Witthuhn","year":"1999","unstructured":"Witthuhn, B.A., Williams, M.D., Kerawalla, H. & Uckun, F.M. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery. Leuk. Lymphoma 32, 289\u2013297 (1999).","journal-title":"Leuk. Lymphoma"},{"key":"BFnchembio2056_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.chembiol.2011.01.012","volume":"18","author":"C Haan","year":"2011","unstructured":"Haan, C. et al. Jak1 has a dominant role over Jak3 in signal transduction through \u03b3c-containing cytokine receptors. Chem. Biol. 18, 314\u2013323 (2011).","journal-title":"Chem. Biol."},{"key":"BFnchembio2056_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/ni.1866","volume":"11","author":"G Perona-Wright","year":"2010","unstructured":"Perona-Wright, G., Mohrs, K. & Mohrs, M. Sustained signaling by canonical helper T cell cytokines throughout the reactive lymph node. Nat. Immunol. 11, 520\u2013526 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnchembio2056_CR14","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1182\/blood-2006-06-027912","volume":"109","author":"L Swainson","year":"2007","unstructured":"Swainson, L. et al. IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. Blood 109, 1034\u20131042 (2007).","journal-title":"Blood"},{"key":"BFnchembio2056_CR15","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1073\/pnas.1301138111","volume":"111","author":"W Liao","year":"2014","unstructured":"Liao, W. et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc. Natl. Acad. Sci. USA 111, 3508\u20133513 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio2056_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4049\/jimmunol.1302291","volume":"192","author":"A Arneja","year":"2014","unstructured":"Arneja, A., Johnson, H., Gabrovsek, L., Lauffenburger, D.A. & White, F.M. Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration. J. Immunol. 192, 123\u2013135 (2014).","journal-title":"J. Immunol."},{"key":"BFnchembio2056_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.6427923","volume":"224","author":"DA Cantrell","year":"1984","unstructured":"Cantrell, D.A. & Smith, K.A. The interleukin-2 T-cell system: a new cell growth model. Science 224, 1312\u20131316 (1984).","journal-title":"Science"},{"key":"BFnchembio2056_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nchembio.1666","volume":"10","author":"N London","year":"2014","unstructured":"London, N. et al. Covalent docking of large libraries for the discovery of chemical probes. Nat. Chem. Biol. 10, 1066\u20131072 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFnchembio2056_CR19","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1074\/jbc.M114.595181","volume":"290","author":"ER Goedken","year":"2015","unstructured":"Goedken, E.R. et al. Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol. J. Biol. Chem. 290, 4573\u20134589 (2015).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio2056_CR20","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1021\/acs.jmedchem.5b00710","volume":"58","author":"L Tan","year":"2015","unstructured":"Tan, L. et al. Development of selective covalent Janus kinase 3 inhibitors. J. Med. Chem. 58, 6589\u20136606 (2015).","journal-title":"J. Med. Chem."},{"key":"BFnchembio2056_CR21","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1021\/jm401490p","volume":"57","author":"JD Clark","year":"2014","unstructured":"Clark, J.D., Flanagan, M.E. & Telliez, J.-B. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases. J. Med. Chem. 57, 5023\u20135038 (2014).","journal-title":"J. Med. Chem."},{"key":"BFnchembio2056_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-065X.2008.00757.x","volume":"228","author":"JA Readinger","year":"2009","unstructured":"Readinger, J.A., Mueller, K.L., Venegas, A.M., Horai, R. & Schwartzberg, P.L. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk\/Txk. Immunol. Rev. 228, 93\u2013114 (2009).","journal-title":"Immunol. Rev."},{"key":"BFnchembio2056_CR23","unstructured":"Ahearn, S.P. et al. Pyrrolopyrimidines as Janus kinase inhibitors. WIPO patent WO085802A1 (2013)."},{"key":"BFnchembio2056_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1074-7613(00)80388-X","volume":"7","author":"P Brennan","year":"1997","unstructured":"Brennan, P. et al. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7, 679\u2013689 (1997).","journal-title":"Immunity"},{"key":"BFnchembio2056_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1182\/blood-2005-12-4827","volume":"108","author":"GH Cornish","year":"2006","unstructured":"Cornish, G.H., Sinclair, L.V. & Cantrell, D.A. Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108, 600\u2013608 (2006).","journal-title":"Blood"},{"key":"BFnchembio2056_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1126\/science.284.5414.638","volume":"284","author":"EM Schaeffer","year":"1999","unstructured":"Schaeffer, E.M. et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284, 638\u2013641 (1999).","journal-title":"Science"},{"key":"BFnchembio2056_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1615\/CritRevImmunol.v26.i3.10","volume":"26","author":"EA Rowell","year":"2006","unstructured":"Rowell, E.A. & Wells, A.D. The role of cyclin-dependent kinases in T-cell development, proliferation, and function. Crit. Rev. Immunol. 26, 189\u2013212 (2006).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnchembio2056_CR28","doi-asserted-by":"publisher","first-page":"11135","DOI":"10.1074\/jbc.M509595200","volume":"281","author":"S Wormald","year":"2006","unstructured":"Wormald, S. et al. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281, 11135\u201311143 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio2056_CR29","doi-asserted-by":"publisher","first-page":"22755","DOI":"10.1074\/jbc.M303021200","volume":"278","author":"AL Cornish","year":"2003","unstructured":"Cornish, A.L. et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other \u03b3 c-dependent cytokines in peripheral T cells. J. Biol. Chem. 278, 22755\u201322761 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio2056_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/ni.2633","volume":"14","author":"XO Yang","year":"2013","unstructured":"Yang, X.O. et al. The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. Nat. Immunol. 14, 732\u2013740 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnchembio2056_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.immuni.2011.12.015","volume":"36","author":"JJ Babon","year":"2012","unstructured":"Babon, J.J. et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 36, 239\u2013250 (2012).","journal-title":"Immunity"},{"key":"BFnchembio2056_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/jpet.113.209304","volume":"348","author":"ME Dowty","year":"2014","unstructured":"Dowty, M.E. et al. Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis. J. Pharmacol. Exp. Ther. 348, 165\u2013173 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnchembio2056_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing, L. et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat. Med. 20, 1043\u20131049 (2014).","journal-title":"Nat. Med."},{"key":"BFnchembio2056_CR34","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","volume":"186","author":"K Ghoreschi","year":"2011","unstructured":"Ghoreschi, K. et al. Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J. Immunol. 186, 4234\u20134243 (2011).","journal-title":"J. Immunol."},{"key":"BFnchembio2056_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth872","volume":"3","author":"PO Krutzik","year":"2006","unstructured":"Krutzik, P.O. & Nolan, G.P. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat. Methods 3, 361\u2013368 (2006).","journal-title":"Nat. Methods"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio.2056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.2056","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio.2056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:41:49Z","timestamp":1684438909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio.2056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFnchembio2056"],"URL":"https:\/\/doi.org\/10.1038\/nchembio.2056","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]},"assertion":[{"value":"18 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}